Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,969 | 128 | 95.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95.00 | 1 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $287.34 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $194.22 | 8 | $0 (2018) |
| PFIZER INC. | $176.60 | 16 | $0 (2024) |
| Amgen Inc. | $170.95 | 13 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $151.84 | 6 | $0 (2018) |
| Allergan Inc. | $132.83 | 9 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $105.08 | 5 | $0 (2024) |
| Lilly USA, LLC | $92.93 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $88.70 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $74.17 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.81 | 14 | Lilly USA, LLC ($45.70) |
| 2023 | $176.53 | 10 | Novartis Pharmaceuticals Corporation ($59.38) |
| 2022 | $97.03 | 7 | Bayer HealthCare Pharmaceuticals Inc. ($26.61) |
| 2020 | $11.80 | 1 | AstraZeneca Pharmaceuticals LP ($11.80) |
| 2019 | $67.85 | 6 | Sunovion Pharmaceuticals Inc. ($67.85) |
| 2018 | $389.54 | 26 | AstraZeneca Pharmaceuticals LP ($77.08) |
| 2017 | $1,087 | 65 | AstraZeneca Pharmaceuticals LP ($184.68) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Gastroenterology | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Bone Health | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.34 | General |
| 03/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: PAIN | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Biological | ||||||
| 01/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Bone Health | ||||||
| 12/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.11 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: PAIN | ||||||
| 08/25/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardio-renal | ||||||
| 07/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Diabetes | ||||||
| 03/13/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Bone Health | ||||||
| 07/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 95 | 117 | $31,617 | $9,872 |
| 2022 | 4 | 92 | 114 | $27,916 | $8,737 |
| 2021 | 4 | 114 | 158 | $29,277 | $9,985 |
| 2020 | 5 | 135 | 170 | $34,222 | $11,828 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 49 | $12,181 | $4,305 | 35.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 23 | $11,170 | $2,870 | 25.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 30 | 31 | $7,768 | $2,613 | 33.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 12 | 14 | $498.00 | $84.70 | 17.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 54 | $8,838 | $2,793 | 31.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 28 | 29 | $7,042 | $2,258 | 32.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,875 | $2,193 | 31.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $5,161 | $1,492 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 66 | $10,329 | $3,618 | 35.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 37 | 39 | $9,037 | $3,171 | 35.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 30 | $9,162 | $3,056 | 33.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 17 | 23 | $748.96 | $141.02 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 65 | $9,945 | $3,641 | 36.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 46 | 47 | $10,419 | $3,462 | 33.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 28 | $8,428 | $2,820 | 33.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $4,866 | $1,787 | 36.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 16 | 18 | $564.00 | $118.71 | 21.0% |
About Dr. James Steckelberg, M.D
Dr. James Steckelberg, M.D is a Family Medicine healthcare provider based in Syracuse, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962419713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Steckelberg, M.D has received a total of $2,064 in payments from pharmaceutical and medical device companies, with $233.81 received in 2024. These payments were reported across 129 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($1,969).
As a Medicare-enrolled provider, Steckelberg has provided services to 436 Medicare beneficiaries, totaling 559 services with total Medicare billing of $40,423. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Syracuse, NE
- Active Since 08/02/2006
- Last Updated 08/31/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1962419713
Products in Payments
- FARXIGA (Drug) $171.14
- TROKENDI XR (Drug) $151.84
- SOLIQUA (Drug) $116.54
- Prolia (Biological) $116.36
- LEQVIO (Drug) $105.08
- XARELTO (Drug) $74.17
- LONHALA MAGNAIR (Drug) $67.85
- JARDIANCE (Drug) $65.15
- MOUNJARO (Drug) $57.85
- BYSTOLIC (Drug) $57.35
- EVENITY (Biological) $54.59
- CHANTIX (Drug) $54.32
- Myrbetriq (Drug) $54.17
- NURTEC ODT (Drug) $50.15
- VIAGRA (Drug) $46.75
- TOUJEO (Drug) $46.06
- SYMBICORT (Drug) $41.81
- Kerendia (Drug) $40.76
- Victoza (Drug) $36.90
- BYDUREON (Drug) $36.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Syracuse
Digant Nanavati, Md, MD
Family Medicine — Payments: $28,844
Carmen Federico, D.o, D.O
Family Medicine — Payments: $21,950
Ted Triana, D.o, D.O
Family Medicine — Payments: $21,439
Dorothy Lennon, Md, MD
Family Medicine — Payments: $13,665
Dr. Scott Bishop, M.d, M.D
Family Medicine — Payments: $12,759
Brett Burtenshaw, Md, MD
Family Medicine — Payments: $10,501